Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Wilcoxon Rank-Sum Test01:21

Wilcoxon Rank-Sum Test

712
The Wilcoxon rank-sum test, also known as the Mann-Whitney U test, is a nonparametric test used to determine if there is a significant difference between the distributions of two independent samples. This test is designed specifically for two independent populations and has the following key requirements:
712
The Mantel-Cox Log-Rank Test01:19

The Mantel-Cox Log-Rank Test

1.0K
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of...
1.0K
Friedman Two-way Analysis of Variance by Ranks01:21

Friedman Two-way Analysis of Variance by Ranks

480
Friedman's Two-Way Analysis of Variance by Ranks is a nonparametric test designed to identify differences across multiple test attempts when traditional assumptions of normality and equal variances do not apply. Unlike conventional ANOVA, which requires normally distributed data with equal variances, Friedman's test is ideal for ordinal or non-normally distributed data, making it particularly useful for analyzing dependent samples, such as matched subjects over time or repeated measures...
480
Wilcoxon Signed-Ranks Test for Median of Single Population01:14

Wilcoxon Signed-Ranks Test for Median of Single Population

436
The Wilcoxon signed-rank test for the median of a single population is a nonparametric test used to evaluate whether the median of a population differs from a specified value. Unlike parametric tests, it does not require data to follow a normal distribution, making it suitable for non-normal or small samples. The test begins by calculating the difference (d) between each observation and the hypothesized median. The absolute values of these differences are ranked in ascending order, with ties...
436
Spearman's Rank Correlation Test01:20

Spearman's Rank Correlation Test

1.4K
Spearman's rank correlation test, also known as Spearman's rho, is a nonparametric method for assessing the strength and direction of association between two variables. This test is particularly valuable when the data distribution is unknown or when the assumption of normality does not hold. Named after the English psychologist and statistician Dr. Charles Edward Spearman, it serves as the nonparametric counterpart to Pearson's correlation coefficient.
Spearman's test calculates correlation by...
1.4K
One-Way ANOVA: Unequal Sample Sizes01:15

One-Way ANOVA: Unequal Sample Sizes

6.6K
One-way ANOVA can be performed on three or more samples of unequal sizes. However, calculations get complicated when sample sizes are not always the same. So, while performing ANOVA with unequal samples size, the following equation is used:
6.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erythrocyte Count, Anemia, and the Human Natural Lifespan Limit: Evidence from the Long Life Family Study.

bioRxiv : the preprint server for biology·2026
Same author

Smart sensing the spectrum: cutting-edge biosensor and biomarker approaches for early autism detection.

Metabolic brain disease·2026
Same author

Longitudinal Sparse Single-Omics Factor Analysis for High-Dimensional Blood Biomarkers in Alzheimer's Disease.

Statistics in medicine·2026
Same author

Deep learning for the joint analysis of item-level longitudinal and survival data.

Journal of applied statistics·2026
Same author

Exploration of Optimal Synergistic Treatment Strategies of Postoperative Radiotherapy and Immunotherapy in Early-Stage Breast Cancer.

Cancers·2026
Same author

Joint modeling of high-dimensional longitudinal data and survival using supervised low-rank tensor decomposition.

Biostatistics (Oxford, England)·2026

Related Experiment Video

Updated: Jan 17, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.1K

Power and Sample Size Calculation for Multivariate Longitudinal Trials Using the Longitudinal Rank Sum Test.

Dhrubajyoti Ghosh1, Xiaoming Xu1, Sheng Luo1

  • 1Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, USA.

Statistics in Medicine
|September 14, 2025
PubMed
Summary

This study introduces a new statistical method for estimating sample sizes needed for clinical trials evaluating treatments for neurodegenerative diseases like Alzheimer's and Parkinson's, using the Longitudinal Rank Sum Test (LRST). This approach ensures trials are adequately powered to detect treatment effects across multiple outcomes.

Keywords:
clinical trial designglobal treatment efficacymultivariate outcomesneurodegenerative diseasesnonparametric inference

More Related Videos

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

11.0K
Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.7K

Related Experiment Videos

Last Updated: Jan 17, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.1K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

11.0K
Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.7K

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Neuroscience

Background:

  • Neurodegenerative diseases (Alzheimer's, Parkinson's) present complex longitudinal outcomes.
  • Evaluating treatment efficacy requires advanced statistical methods for multivariate data.
  • Existing methods may necessitate multiplicity corrections, complicating analysis.

Purpose of the Study:

  • To develop a robust methodology for power and sample size estimation for the Longitudinal Rank Sum Test (LRST).
  • To provide a framework for designing efficient, well-powered clinical trials for complex neurodegenerative diseases.
  • To facilitate the evaluation of global treatment effects across multiple longitudinal endpoints without multiplicity corrections.

Main Methods:

  • Developed a nonparametric framework for the Longitudinal Rank Sum Test (LRST).
  • Integrated theoretical derivations and asymptotic properties for power and sample size calculations.
  • Employed practical estimation techniques suitable for large sample conditions.

Main Results:

  • Numerical simulations validated the accuracy of the proposed power and sample size estimation methods for LRST.
  • The methodology was successfully applied to real-world clinical trial data for Alzheimer's disease (AD) and Parkinson's disease (PD).
  • Demonstrated the practical significance and applicability of the developed framework in clinical settings.

Conclusions:

  • The proposed methodology provides a reliable tool for sample size and power estimation for LRST.
  • This framework enhances the design of clinical trials for neurodegenerative diseases with multivariate longitudinal outcomes.
  • Facilitates more efficient and powerful evaluations of treatment efficacy in complex disease research.